Mono Pharmacare Financials

₹8.95

₹0.00 (0.00%)

As on 04-Sep-2026 15:32IST

Market cap

₹16 Cr

Revenue (TTM)

₹168 Cr

P/E Ratio

44.8

P/B Ratio

0.5

Div. Yield

0 %

Income Statement (₹ Cr)	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Operating Revenue	168.34	122.34	26.99	--	--	--
Total Income	169.32	122.44	27.22	--	--	--
Total Expenditure	160.71	116.01	25.48	--	--	--
EBITDA	7.64	6.33	1.52	--	--	--
Depreciation	0.13	0.12	0.05	--	--	--
EBIT	7.51	6.21	1.47	--	--	--
Interest	4.03	3.08	0.77	--	--	--
Other Income	0.98	0.10	0.23	--	--	--
Exceptional Items	--	--	--	--	--	--
Profit before Tax	4.46	3.23	0.93	--	--	--
Provision for Tax	1.36	0.77	0.23	--	--	--
Profit after Tax	3.11	2.46	0.70	--	--	--
Minority Interest	-0.02	-0.02	0.00	--	--	--
Share of Associate	--	--	--	--	--	--
Consolidated Profit	3.09	2.44	0.70	--	--	--

Liabilities (₹ Cr)	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Shareholder's Funds	31.20	28.11	13.38	--	--	--
Minority Interest	0.04	0.02	0.01	--	--	--
Non-Current Liabilities	26.00	17.16	17.96	--	--	--
Current Liabilities	52.78	35.82	31.20	--	--	--
Total Liabilities	110.05	81.11	62.60	--	--	--

Assets (₹ Cr)	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Non-Current Assets	1.02	0.94	1.43	--	--	--
Current Assets	108.99	80.16	61.12	--	--	--
Total Assets	110.05	81.11	62.60	--	--	--
Total Debt*	53.56	41.44	40.50	--	--	--
Net Current Assets	56.21	44.35	29.92	--	--	--
Contingent Liabilities	--	--	--	--	--	--

Cashflow (₹ Cr)	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Cash From Operating Activities	-4.30	-8.77	-27.75	--	--	--
Cash Flow from Investing Activities	-0.23	0.40	-1.44	--	--	--
Cash from Financing Activities	4.86	8.32	29.61	--	--	--
Net Cash Inflow / Outflow	0.33	-0.06	0.42	--	--	--

Financials Ratios	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Adjusted EPS (₹)	1.75	1.38	0.57	--	--	--
Cash EPS (₹)	1.83	1.46	0.61	--	--	--
Adjusted Book Value (₹)	17.66	15.91	10.82	--	--	--
Dividend per Share (₹)	--	--	--	--	--	--
Cash Flow per Share (₹)	-2.44	-4.96	-22.44	--	--	--
Free Cash Flow per Share (₹)	-4.82	-6.83	-23.94	--	--	--

Profitability Ratios	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
ROCE (%)	11.00	10.22	3.16	--	--	--
ROE (%)	10.47	11.85	5.24	--	--	--
ROA (%)	3.25	3.42	1.12	--	--	--
EBIT Margin (%)	4.46	5.08	5.44	--	--	--
Net Margin (%)	1.83	2.01	2.58	--	--	--
Cash Profit Margin (%)	1.92	2.10	2.77	--	--	--

Growth Ratios	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Revenue Growth (%)	37.60	353.27	--	--	--	--
EBIT Growth (%)	20.86	323.26	--	--	--	--
Net Profit Growth (%)	26.32	250.51	--	--	--	--
EPS Growth (%)	26.53	144.35	--	--	--	--
Book Value Growth (%)	10.99	110.03	--	--	--	--

Valuation Ratios	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Price / Earnings	13.21	31.90	--	--	--	--
Price / Book Value	1.31	2.77	--	--	--	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	10.87	18.52	30.01	--	--	--
Close Price (₹)	23.10	44.10	--	--	--	--
High Price (₹)	54.00	75.00	--	--	--	--
Low Price (₹)	22.10	28.00	--	--	--	--
Market Cap (₹ Cr)	40.81	77.92	--	--	--	--

Solvency Ratios	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Debt to Equity	1.72	1.47	3.03	--	--	--
Short term debt to equity ratio	0.88	0.87	1.68	--	--	--
Current Ratio	2.07	2.24	1.96	--	--	--
Quick Ratio	1.02	1.06	0.91	--	--	--
Interest Coverage	2.11	2.05	2.21	--	--	--

Operating Efficiency Ratios	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Debtors to sales (%)	24.88	25.82	81.03	--	--	--
Asset Turnover	1.76	1.70	0.43	--	--	--
Receivable days	79.66	79.75	295.76	--	--	--
Inventory Days	105.89	111.85	442.02	--	--	--
Payable days	34.13	27.14	102.92	--	--	--
Cash Conversion Cycle	151.42	164.46	634.87	--	--	--